Pfizer expects to submit COVID-19 vaccine for children ages 2 to 11 years old authorization request in September

Pfizer expects to submit COVID-19 vaccine for children ages 2 to 11 years old authorization request in September

Pfizer expects to submit COVID-19 vaccine for children ages 2 to 11 years old authorization request in September

Download PDF

Pfizer expects to submit for U.S. FDA emergency use authorization its COVID-19 vaccine for children ages 2 to 11-years-old in September, the company said.

The “pediatric safety and efficacy study” in children age 6 months to 11-years-old continues.

Scroll to Top

Sharing a story can change the world.